STAAR Surgical ends interim leadership, names Warren Foust permanent CEO with options tied to a more than doubling of the stock price
STAA sits 47% above its 52-week low of $15.585 on light trading volume (0.2× avg).
Summary
STAAR Surgical appointed Warren Foust as permanent CEO and granted him performance options that vest only if the stock reaches $50, $75, or $100—more than double today's price. CFO Deborah Andrews was promoted to EVP.
Key Events · Executive and Board Changes · STAA
-
CEO Appointment Finalized
Warren Foust, who served as Interim Co-CEO since February 2026, was appointed permanent President and CEO effective August 4, 2026, ending a six-month leadership transition.
-
Performance-Linked Equity Grant
Foust received 395,494 performance-vesting options that vest only if STAAR's 60-day VWAP reaches $50, $75, or $100—more than double the current $22.89 price—plus 67,479 RSUs and 121,413 time-vesting options.
-
CFO Promotion
Deborah Andrews, who served as Interim Co-CEO alongside Foust, was appointed Executive Vice President and will continue as CFO, receiving 4,975 RSUs and 38,111 options (including 29,159 performance-based).
-
High Bar for Shareholder Value
The performance options require the stock to more than double before any shares vest, aligning management incentives with a significant recovery from the recent 12% post-earnings drop.
Analysis · STAA · Industrial Applications And Services
After a six-month interim period, STAAR Surgical appoints Warren Foust as permanent CEO, closing the leadership gap. His compensation package heavily weights equity toward performance options that require the stock to reach $50, $75, or $100—more than double the current $22.89 share price—directly aligning his incentives with a dramatic recovery. The board also promotes CFO Deborah Andrews to EVP, underscoring confidence in the team that delivered record first-half results. While the performance options create potential dilution, they only kick in if the stock more than doubles, setting a high-water mark for shareholder value creation.
How filings like this one have moved
In the 30 days to Oct 2, 2026, 29.4% of the 1637 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.57%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, STAA was trading at $22.89 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $1.1B. The 52-week trading range was $15.59 to $35.87. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.